- Home
- ACLS vs HCM Comparison
ACLS vs HCM Comparison
Compare ACLS & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLS
- HCM
- Stock Information
- Founded
- ACLS 1995
- HCM 2000
- Country
- ACLS United States
- HCM Hong Kong
- Employees
- ACLS N/A
- HCM N/A
- Industry
- ACLS Industrial Machinery/Components
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- ACLS Technology
- HCM Health Care
- Exchange
- ACLS Nasdaq
- HCM Nasdaq
- Market Cap
- ACLS 2.2B
- HCM 2.8B
- IPO Year
- ACLS 2000
- HCM N/A
- Fundamental
- Price
- ACLS $80.04
- HCM $15.01
- Analyst Decision
- ACLS Buy
- HCM
- Analyst Count
- ACLS 5
- HCM 0
- Target Price
- ACLS $90.00
- HCM N/A
- AVG Volume (30 Days)
- ACLS 563.4K
- HCM 54.1K
- Earning Date
- ACLS 08-05-2025
- HCM 08-07-2025
- Dividend Yield
- ACLS N/A
- HCM N/A
- EPS Growth
- ACLS N/A
- HCM N/A
- EPS
- ACLS 4.91
- HCM 0.53
- Revenue
- ACLS $896,089,000.00
- HCM $602,197,000.00
- Revenue This Year
- ACLS N/A
- HCM $2.73
- Revenue Next Year
- ACLS $5.27
- HCM $17.33
- P/E Ratio
- ACLS $16.31
- HCM $5.52
- Revenue Growth
- ACLS N/A
- HCM N/A
- 52 Week Low
- ACLS $40.40
- HCM $11.51
- 52 Week High
- ACLS $113.37
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- ACLS 54.35
- HCM 38.45
- Support Level
- ACLS $79.78
- HCM $14.75
- Resistance Level
- ACLS $82.77
- HCM $16.30
- Average True Range (ATR)
- ACLS 2.71
- HCM 0.28
- MACD
- ACLS -0.26
- HCM -0.15
- Stochastic Oscillator
- ACLS 30.19
- HCM 14.29
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.